Neuroendocrine, Autonomic, and Metabolic Responses to an Orexin Antagonist, Suvorexant, in Psychiatric Patients with Insomnia.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Innovations in Clinical Neuroscience

• Publication date

  2017-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 28584695PMCID PMC5451036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.

  2016cited by this paper
• Orexin and Metabolism

  2015cited by this paper
• Hypothalamic Orexin Prevents Hepatic Insulin Resistance via Daily Bidirectional Regulation of Autonomic Nervous System in Mice

  2014cited by this paper
• Rotating night shifts too quickly may cause anxiety and decreased attentional performance, and impact prolactin levels during the subsequent day: a case control study

  2014cited by this paper
• Orexin modulation of adipose tissue.

  2014cited by this paper
• Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.

  2014cited by this paper
• Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and Alprazolam following insulin-induced hypoglycemia in humans

  2014cited by this paper
• Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats

  2013cited by this paper
• Cooperation between brain and islet in glucose homeostasis and diabetes

  2013cited by this paper
• Role of orexin in the central regulation of glucose and energy homeostasis.

  2012cited by this paper
• Suprachiasmatic nucleus and autonomic nervous system influences on awakening from sleep.

  2010cited by this paper
• Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system.

  2009cited by this paper
• Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress.

  2007cited by this paper
• Distribution of orexin neurons in the adult rat brain

  2007cited by this paper
• A brief measure for assessing generalized anxiety disorder: the GAD-7.

  2006cited by this paper
• Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells.

  2005cited by this paper
• Hypothalamic regulation of sleep and circadian rhythms

  2005cited by this paper
• Hypothalamic‐Pituitary‐Adrenal Responses to Centrally Administered Orexin‐A are Suppressed in Pregnant Rats

  2003cited by this paper
• Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats.

  2003cited by this paper
• Attenuated defense response and low basal blood pressure in orexin knockout mice.

  2003cited by this paper
• Hypothalamic orexin neurons regulate arousal according to energy balance in mice.

  2003cited by this paper
• Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice.

  2002cited by this paper
• Dynamics of the pituitary-adrenal ensemble in hypocretin-deficient narcoleptic humans: blunted basal adrenocorticotropin release and evidence for normal time-keeping by the master pacemaker.

  2002cited by this paper
• Selective Activation of the Extended Ventrolateral Preoptic Nucleus during Rapid Eye Movement Sleep

  2002cited by this paper
• Orexins and the treatment of obesity.

  2002cited by this paper
• Differential expression of orexin receptors 1 and 2 in the rat brain

  2001cited by this paper
• The PHQ-9: validity of a brief depression severity measure.

  2001cited by this paper
• Prolonged orexin administration stimulates steroid-hormone secretion, acting directly on the rat adrenal gland.

  2001cited by this paper
• Central Orexin‐A Activates Hypothalamic‐Pituitary‐Adrenal Axis and Stimulates Hypothalamic Corticotropin Releasing Factor and Arginine Vasopressin Neurones in Conscious Rats

  2001cited by this paper
• Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

  2001cited by this paper
• Central Administration of Orexin A Suppresses Basal and Domperidone Stimulated Plasma Prolactin

  2000cited by this paper
• Reduced Number of Hypocretin Clinical Study Neurons in Human Narcolepsy

  2000cited by this paper
• Centrally administered orexin/hypocretin activates HPA axis in rats

  2000cited by this paper
• Prolactin: structure, function, and regulation of secretion.

  2000cited by this paper
• Sympathetic and cardiovascular actions of orexins in conscious rats.

  1999cited by this paper
• Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

  1999cited by this paper
• Distribution of orexin neurons in the adult rat brain.

  1999cited by this paper
• Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems.

  1999cited by this paper
• Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

  1999cited by this paper
• The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

  1998cited by this paper
• Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

  1998cited by this paper
• Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems

  1998cited by this paper
• Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes.

  1998cited by this paper
• Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

  1998cited by this paper
• Catecholamine-induced leukocytosis: early observations, current research, and future directions.

  1996cited by this paper
• The lateral hypothalamic area revisited: ingestive behavior.

  1996cited by this paper
• The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

  1989cited by this paper

• Functional Plasticity of Orexin/Hypocretin Neurons Balances Stress States.

  2025cites this paper
• Efficacy and safety profiles of FDA-approved dual orexin receptor antagonists in depression: A systematic review of pre-clinical and clinical studies.

  2025cites this paper
• Hypocretin modulation of behavioral coping strategies for social stress.

  2024cites this paper
• The Orexin OX2 Receptor‐Dependent Pathway Is Implicated in the Development of Overactive Bladder and Depression in Rats Exposed to Corticosterone

  2024cites this paper
• Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review

  2024influential citation
• Orexin Receptor Antagonists as Adjunct Drugs for the Treatment of Depression: A Mini Meta-Analysis.

  2024cites this paper
• International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology

  2024cites this paper
• The importance of sleep in the paradigm shift from a tissue- and disease-based pain management approach towards multimodal lifestyle interventions for chronic pain.

  2024cites this paper
• Identification of a novel perifornical-hypothalamic-area-projecting serotonergic system that inhibits innate panic and conditioned fear responses

  2024cites this paper
• Personalized Multimodal Lifestyle Intervention as the Best-Evidenced Treatment for Chronic Pain: State-of-the-Art Clinical Perspective

  2024cites this paper
• The Biology of Stress Intolerance in Patients with Chronic Pain—State of the Art and Future Directions

  2023cites this paper
• Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities.

  2023cites this paper
• The role of the orexin system in the neurobiology of anxiety disorders: Potential for a novel treatment target

  2023cites this paper
• From sleep to cancer to neurodegenerative disease: the crucial role of Hsp70 in maintaining cellular homeostasis and potential therapeutic implications

  2023cites this paper
• Role of the orexin system in the bidirectional relation between sleep and epilepsy: New chances for patients with epilepsy by the antagonism to orexin receptors?

  2023cites this paper
• Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions

  2023cites this paper
• Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders

  2023cites this paper
• Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database

  2023cites this paper
• The association between serum orexin-A levels and sleep quality in pregnant women.

  2022cites this paper
• Alteration of gamma-aminobutyric acid in the left dorsolateral prefrontal cortex of individuals with chronic insomnia: a combined transcranial magnetic stimulation-magnetic resonance spectroscopy study.

  2022cites this paper
• Assessment of Suvorexant and Eszopiclone as Alternatives to Benzodiazepines for Treating Insomnia in Patients With Major Depressive Disorder

  2022cites this paper
• Agonists and antagonists of the orexinergic system: therapeutic molecules of the future - a narrative review

  2022cites this paper
• Behavioural, medical & environmental interventions to improve sleep quality for mental health inpatients in secure settings: a systematic review & meta-analysis

  2022influential citation
• Effects of anti‐seizure therapies on sleep in patients with epilepsy: A literature review

  2022cites this paper
• Orexin, Sleep, Sympathetic Neural Activity, and Cardiovascular Function

  2022cites this paper
• Body Weight and Metabolic Rate Changes in Narcolepsy: Current Knowledge and Future Directions

  2022cites this paper
• Sleep and Circadian Rhythm Disturbances in Diabetes: A Narrative Review

  2022cites this paper
• Orexin A Enhances Pro-Opiomelanocortin Transcription Regulated by BMP-4 in Mouse Corticotrope AtT20 Cells

  2021cites this paper
• medical patients: A review article Sleep disturbance in hospitalized

  2021cites this paper
• Hypothalamic stress systems in mood disorders.

  2021cites this paper
• Circadian rhythm sleep-wake disturbances and depression in young people: implications for prevention and early intervention.

  2021cites this paper
• Epilepsy, sleep and neuropeptides. Future directions

  2021cites this paper
• Sleep and anxiety: From mechanisms to interventions.

  2021cites this paper
• Diversity and molecular network patterns of symptom phenotypes

  2021cites this paper
• Similar Effects of an Orexin Receptor Antagonistand Benzodiazepine Receptor Agonist on Cerebral Blood Flow Regulation

  2021cites this paper
• Increased Hypocretin (Orexin) Plasma Level in Depression, Bipolar Disorder Patients

  2021cites this paper
• Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy.

  2020cites this paper
• Sleep interventions and glucose metabolism: systematic review and meta-analysis.

  2020cites this paper
• Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: behavioural and neurochemical analyses.

  2020cites this paper
• Hypocretin (Orexin) Replacement Therapies

  2020cites this paper
• Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity

  2020cites this paper
• Orexin A in adolescents with anxiety disorders

  2020influential citation
• Lifestyle and Chronic Pain across the Lifespan: An Inconvenient Truth?

  2020cites this paper
• How broken sleep promotes cardiovascular disease

  2019cites this paper
• The Effect of sequential bilateral low‐frequency rTMS over dorsolateral prefrontal cortex on serum level of BDNF and GABA in patients with primary insomnia

  2019cites this paper
• Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.

  2019cites this paper
• Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders

  2019cites this paper
• Best Evidence Rehabilitation for Chronic Pain Part 3: Low Back Pain

  2019cites this paper
• Pharmacology of Orexin/Hypocretin Receptors

  2019cites this paper
• Cardiovascular reactivity and psychological hyperarousal in hot flash-associated insomnia disorder.

  2019cites this paper
• Sleep Disturbances in Chronic Pain: Neurobiology, Assessment, and Treatment in Physical Therapist Practice

  2018cites this paper
• Orexins and stress.

  2018cites this paper
• Suvorexant as an orexin antagonist may regulate serum glucose levels in psychiatric patients with insomnia

  2017cites this paper